'Hunger-buster' diabetes jab helps obese lose 20% of their weight, trial finds

A “game-changing” diabetes drug helped obese volunteers shed 20% of their body weight in a clinical trial.

For the study, 2,500 people in nine countries injected themselves with either tirzepatide or a placebo once a week for 72 weeks.

Of those given the highest dose of tirzepatide, 57% lost 20% or more of their body weight.